Public Employees Retirement System Of Ohio Ngm Biopharmaceuticals Inc Transaction History

Public Employees Retirement System Of Ohio

$25.2 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 19, 2023	SELL	$2.44 - $4.53 $2,440 - $4,530	-1,000 Reduced 2.02%	48,424 $125,000
Q2 2023 Aug 15, 2023	SELL	$2.44 - $4.53 $2,440 - $4,530	-1,000 Reduced 2.02%	48,424 $125,000
Q4 2022 Dec 19, 2023	BUY	$3.41 - $12.93 $3,410 - $12,930	1,000 Added 2.07%	49,424 $248,000
Q4 2022 Feb 15, 2023	BUY	$3.41 - $12.93 $168,535 - $639,052	49,424 New	49,424 $248,000
Q2 2022 Aug 15, 2022	SELL	$10.58 - $17.5 $193,370 - $319,847	-18,277 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $176,146 - $237,243	-12,755 Reduced 41.1%	18,277 $279,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $625,294 - $812,728	31,032 New	31,032 $652,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account